Sartorius Aktiengesellschaft
SRT3.DE · XETRA
Bulios Fair Price
231.64 €
8.3% downside
Current Price
252.5 €
According to Bulios Fair Price, SRT3.DE is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Sartorius Aktiengesellschaft (SRT) is a German company specializing in the manufacturing of laboratory technologies and equipment for the pharmaceutical and biotechnology industries. Their portfolio includes a wide range of products, including laboratory weighing devices, bioreactors, filters, pipettes, and analytical tools for drug development and manufacturing. Sartorius Aktiengesellschaft focuses on providing high-quality and innovative products that help pharmaceutical companies and research institutions achieve better results in drug development and biotechnological processes. The company also invests in research and development of new technologies to continuously innovate its products and services. Sartorius Aktiengesellschaft (SRT) shares may be attractive to investors seeking investments in companies operating in the laboratory technology field with an emphasis on innovation and quality.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Grosse
Employees
14,279
Headquarters
Göttingen
Upcoming events
Earnings
Upcoming earnings report